Bio Elpida is a biotechnology contract development and manufacturing organisation (CDMO) based in Lyon, France, specialising in the pre-clinical and clinical development of cell therapies and bio-products.

Founded in 2009, Bio Elpida provides end-to-end services across various stages of development, from R&D through to GMP-compliant manufacturing. With deep expertise in cell culture and innovative cell therapy, the company is a trusted partner for biopharmaceutical companies developing novel therapies, particularly in immunotherapy and cancer vaccines.

Key Products and Services

• Cell culture and bacterial fermentation
• Innovative cell therapies, including anti-cancer vaccines and immunotherapies
• Research and feasibility studies
• Pharmaceutical development
• Clinical batch manufacturing and quality control
• Aseptic fill and finish
• Testing services and analytical development
• Regulatory support and IMPD preparation

With its expertise and certified facilities, Bio Elpida remains at the forefront of advancing cellular and biotechnological innovations, helping to deliver life-changing therapies to the global market.